OpenInsiders01Web Canada
SEC INSIDER TRANSACTIONS

STERIS plc (STE) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

STE · STERIS plc

How to read this data ↗
More transaction filters

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters
Stale snapshot · Covered: filings 2026-10-15 to 2026-11-13 · 2 filings · fetched 2026-11-13T20:00:25Z

View six-calendar-month insider history →

Recent reported activity

0purchase rows on this page
3sale rows on this page
7matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filedReporting owner(s)Code / securityQuantityPrice as filedOwnershipSource
2026-11-11Filed 2026-11-12Burton Karen LOfficer · Sr. Vice Pres., CFO
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Price reflects a weighted average sale price for multiple transactions ranging from $255.22 to $256.18 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2 As of November 12, 2026, 8,499 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028; 783 on October 1, 2028 and 1,775 on June 4, 2029.

F3 This option to purchase 5,880 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 5,880 ordinary shares for $147.05 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.

References: F3

M Exercise / conversionEmployee Stock Option (right to buy) · Derivative5,880D0DirectForm 4 ↗0001628280-26-073444
2026-11-11Filed 2026-11-12Burton Karen LOfficer · Sr. Vice Pres., CFO
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Price reflects a weighted average sale price for multiple transactions ranging from $255.22 to $256.18 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2 As of November 12, 2026, 8,499 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028; 783 on October 1, 2028 and 1,775 on June 4, 2029.

F3 This option to purchase 5,880 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 5,880 ordinary shares for $147.05 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.

References: F1, F2

S Sale (market/private)Ordinary Shares · Non-derivative5,880D255.62DirectForm 4 ↗0001628280-26-073444
2026-11-11Filed 2026-11-12Burton Karen LOfficer · Sr. Vice Pres., CFO
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Price reflects a weighted average sale price for multiple transactions ranging from $255.22 to $256.18 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2 As of November 12, 2026, 8,499 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028; 783 on October 1, 2028 and 1,775 on June 4, 2029.

F3 This option to purchase 5,880 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 5,880 ordinary shares for $147.05 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.

References:

M Exercise / conversionOrdinary Shares · Non-derivative5,880A147.05DirectForm 4 ↗0001628280-26-073444
2026-11-10Filed 2026-11-12Sohi MohsenDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Price reflects a weighted average sale price for multiple transactions ranging from $252.66 to $253.43 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2 Price reflects a weighted average sale price for multiple transactions ranging from $253.69 to $254.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3 This option to purchase 4,893 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,893 ordinary shares for $114.74 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.

References: F3

M Exercise / conversionDirector Stock Option (right to buy) · Derivative4,893D0DirectForm 4 ↗0001628280-26-073442
2026-11-10Filed 2026-11-12Sohi MohsenDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Price reflects a weighted average sale price for multiple transactions ranging from $252.66 to $253.43 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2 Price reflects a weighted average sale price for multiple transactions ranging from $253.69 to $254.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3 This option to purchase 4,893 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,893 ordinary shares for $114.74 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.

References: F2

S Sale (market/private)Ordinary Shares · Non-derivative1,665D253.9DirectForm 4 ↗0001628280-26-073442
2026-11-10Filed 2026-11-12Sohi MohsenDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Price reflects a weighted average sale price for multiple transactions ranging from $252.66 to $253.43 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2 Price reflects a weighted average sale price for multiple transactions ranging from $253.69 to $254.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3 This option to purchase 4,893 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,893 ordinary shares for $114.74 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.

References: F1

S Sale (market/private)Ordinary Shares · Non-derivative3,228D252.87DirectForm 4 ↗0001628280-26-073442
2026-11-10Filed 2026-11-12Sohi MohsenDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Price reflects a weighted average sale price for multiple transactions ranging from $252.66 to $253.43 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2 Price reflects a weighted average sale price for multiple transactions ranging from $253.69 to $254.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3 This option to purchase 4,893 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,893 ordinary shares for $114.74 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.

References:

M Exercise / conversionOrdinary Shares · Non-derivative4,893A114.74DirectForm 4 ↗0001628280-26-073442

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.